World Arthritis Day

World Arthritis Day

Arthritis is a common chronic disease affecting people of all ages. In Australia alone, approximately 15% of the population have some form of arthritis, with osteoarthritis being the most common.

12 October marks World Arthritis Day. Help us raise awareness. If you are one of many who are affected by osteoarthritis, know that there may be options available.

For more information, please fill out the form below.

 

 


Osteoarthritis inquiry

  • DISCLAIMER

    At Metro Pain Group, we assess each patient’s condition individually. As leaders in pain intervention, we aim to provide advanced, innovative and evidence-based treatments tailored to suit the patient. The suitability of our procedures varies from patient to patient. If you would like to find out if this or other treatments are suitable for your specific condition, please speak to one of our doctors at the time of your consultation.

  • This field is for validation purposes and should be left unchanged.

Treatment for ongoing knee pain

treatment for ongoing knee pain

Do you experience knee pain that is worse in the morning, but improves as the day progresses?

 

Do you feel burning sensations, buzzing and numbness in your knees?

 

Do you experience severe pain that often wakes you up at night?

 

The knee is a complex joint. Ongoing knee pain from osteoarthritis can come from multiple sources. In 30% of cases, the pain does not actually come from the joint itself.1 The knee is surrounded by connective tissues, ligaments and bone which are all rich in nerves, and the likely source of pain. In some cases even nerves that well away from the knee area can also be common sources of pain.

At Metro Pain Group, we have a range of options available. With our unique approach, we offer treatment strategies for the long term reduction and management of pain.  Depending on the patient’s specific condition, we offer:

  • General advice
  • Medication management
  • Psychology and rehab
  • Delivery of injectables including steroids, hyaluron, PRP and stem cells
  • Recommendation of orthopaedic devices
  • Diagnostic procedures
  • Interventional treatments

 

If you are looking for options to relieve your pain and would like more information, please fill out the form below.

 

References:

1 Dieppe, P.A. and Lohmander, L.S., 2005. Pathogenesis and management of pain in osteoarthritis. The Lancet365(9463), pp.965-973.

 


Ongoing knee pain inquiry

  • DISCLAIMER

    At Metro Pain Group, we assess each patient’s condition individually. As leaders in pain intervention, we aim to provide advanced, innovative and evidence-based treatments tailored to suit the patient. The suitability of our procedures varies from patient to patient. If you would like to find out if this or other treatments are suitable for your specific condition, please speak to one of our doctors at the time of your consultation.

  • This field is for validation purposes and should be left unchanged.

September is Pain Awareness Month

Pain Awareness Month

Pain Awareness Month is a time when various organisations work together to raise public awareness of issues in the area of pain and pain management. The initiative was introduced by the American Chronic Pain Association under the Partners for Understanding Pain banner in 2001.

This year, the International Alliance of Patient Organizations and International Pain Management Network joins the initiative to bring pain to the forefront of the international community. Raise awareness by getting involved. Talk to your family, friends and healthcare team and help create greater understanding of pain.

neuropathic pain

What is neuropathic pain?

neuropathic pain

Neuropathic pain commonly presents as burning, pins & needles, numbness, electric shocks or itching. It has multiple causes including nerve injury, spinal cord damage and complications from shingles. Neuropathic pain can also arise following a surgical procedure.

Around 7–8% of adults experience pain that can be described as neuropathic, as well as one in four people with diabetes.  Managing neuropathic pain can be challenging. It is associated with impaired quality of life and is often poorly managed, partly because neuropathic pain is often unrecognised by healthcare practitioners.

At Metro Pain Group, we regularly treat patients with neuropathic pain. We offer advanced and evidence-based treatment measures in conjunction with multidisciplinary care.

For more information, please fill out the form below.

 

References:

Costigan, M., Scholz, J. and Woolf, C.J., 2009. Neuropathic pain: a maladaptive response of the nervous system to damage. Annual review of neuroscience32, pp.1-32.
Dworkin, R.H., O’Connor, A.B., Kent, J., Mackey, S.C., Raja, S.N., Stacey, B.R., Levy, R.M., Backonja, M., Baron, R., Harke, H. and Loeser, J.D., 2013. Interventional management of neuropathic pain: NeuPSIG recommendations. PAIN®154(11), pp.2249-2261.
Freynhagen, R. and Bennett, M.I., 2009. Diagnosis and management of neuropathic pain. Bmj339(b3002).
International Association for the Study of Pain. Epidemiology of neuropathic pain: how common is neuropathic pain, and what is its impact? Washington: IASP; 2014.
Smith, B.H. and Torrance, N., 2012. Epidemiology of neuropathic pain and its impact on quality of life. Current pain and headache reports16(3), pp.191-198.

 


Neuropathic pain inquiry

  • DISCLAIMER

    At Metro Pain Group, we assess each patient’s condition individually. As leaders in pain intervention, we aim to provide advanced, innovative and evidence-based treatments tailored to suit the patient. The suitability of our procedures varies from patient to patient. If you would like to find out if this or other treatments are suitable for your specific condition, please speak to one of our doctors at the time of your consultation.

  • This field is for validation purposes and should be left unchanged.

Workplace Injury

  • Is your workplace injury causing you pain?
  • Have you received a less than optimal outcome from your treatment?
  • Are you having challenges with obtaining approval for your pain treatment?

If you answered yes, to any of the questions, Metro Pain Group can help.

  • We have a multidisciplinary team of Pain Doctors, Psychologists, Physiotherapists, Physician Associates and a Rehab Coordinator
  • Our Team can help you get back to doing what you love.
  • We can also act on your behalf when requesting approvals and other matters.

 

If your pain is a result of a workplace injury and would like to find out how we can help, please fill out the form below or contact 03 9595 6195:

Find out how we can help

  • This field is for validation purposes and should be left unchanged.

Advanced treatment for chronic headaches and migraines yields positive results

headaches and migraines

People who experience daily headaches and migraines often find that the pain hinders their day to day living. Their work, family and social life can also be affected when their pain is not well managed.

While there are many conventional treatments for headaches and migraines, some patients unfortunately do not get relief.  At Metro Pain Group we offer patients several options to alleviate headaches and migraines such as medications, physical and psychological treatments and procedures.

When conservative treatments have been unsuccessful, patients may seek alternative options.

In a long term study of 60 cases, Peripheral Nerve Field Stimulation (PNFS), a type of neuromodulation, has shown encouraging results. [i] Almost 70% of patients who underwent the procedure reported significant pain relief (>50%). [i]  Medication use was reduced for the majority of patients (83%) who were previously taking pain relief or prevention medication. Additionally, reductions in disability and depression were reported allowing patients to return to normal activity. [i]

As with any procedure, PNFS carries possible risks and side effects, however the treatment is reversible and can potentially bring relief to patients who have unsuccessfully tried other therapies.

If you are experiencing ongoing headaches and migraines and would like more information, please fill out the form below.

___________________

[i] Verrills P., Rose R., Mitchell B., Vivian D., Barnard A. 2013. Peripheral Nerve Field Stimulation for Chronic Headache: 60 Cases and Long-Term Follow-Up. Neuromodulation 2013; e-pub ahead of print. DOI: 10.1111/ner.12130

 

Headaches and migraines - more information

  • DISCLAIMER

    At Metro Pain Group, we assess each patient’s condition individually. As leaders in pain intervention, we aim to provide advanced, innovative and evidence-based treatments tailored to suit the patient. The suitability of our procedures varies from patient to patient. If you would like to find out if this or other treatments are suitable for your specific condition, please speak to one of our doctors at the time of your consultation.

  • This field is for validation purposes and should be left unchanged.

Would you like to find out more about the latest in pain treatments?

latest in pain treatments

Metro Pain Group has a wholly owned research subsidiary, Monash Clinical Research (MCR), who run clinical studies together with our doctors to help find new or improved treatments for patients suffering from chronic pain.

MCR is currently running several clinical trials, with more due to start later this year.

Some of the conditions being investigated include:

  • Failed Back Surgery Syndrome
  • Chronic Lower Back Pain
  • Chronic Leg Pain
  • Shoulder Pain

 

WorkCover/TAC/DVA and uninsured patients can also participate in some of these studies.

To find out more about our clinical trials, please fill out the form below and one of our research coordinators will be in touch.

 

Find out about the latest in pain treatments

  • DISCLAIMER

    At Metro Pain Group, we assess each patient’s condition individually. As leaders in pain intervention, we aim to provide advanced, innovative and evidence-based treatments tailored to suit the patient. The suitability of our procedures varies from patient to patient. If you would like to find out if this or other treatments are suitable for your specific condition, please speak to one of our doctors at the time of your consultation.

  • This field is for validation purposes and should be left unchanged.

Can Radiofrequency Neurotomy be repeated?

radiofrequency neurotomy

Radiofrequency Neurotomy (RFN) is a treatment used to bring relief to neck or back pain caused by facet joints. 1,2 The procedure is performed under fluoroscopy under sterile conditions in an operating theatre using mild sedation and local anaesthetic. Using a radiofrequency generator, the procedure involves placing a probe alongside the affected nerve. The probe is heated to 90 degrees Celsius. Pain signals are interrupted as a result which can bring pain relief for a long period until full nerve function recovers.

A small portion of patients may find that their pain is gone for good; however most patients may find that the effects are temporary and that the pain could return 6 to 18 months following the procedure. In such cases, the procedure can be repeated. Studies have found that patients who have previously responded well to the treatment are usually successful when they undergo subsequent treatments. 3

If you have previously had radiofrequency neurotomy and find that your pain is returning, please fill out the form below for more information.

References:
1 McDonald GJ, Lord SM, Bogduk N. Long-term follow-up of patients treated with cervical radiofrequency neurotomy for chronic neck pain. Neurosurgery 1999:45: 61-68
2 Dreyfuss, P., Halbrook, B., Pauza, K., Joshi, A., McLarty, J., & Bogduk, N. (2000). Efficacy and validity of radiofrequency neurotomy for chronic lumbar zygapophysial joint pain. Spine, 25(10), 1270-1277.
3 Husted, D. S., Orton, D., Schofferman, J. and Kine, G. (2008), Effectiveness of Repeated Radiofrequency Neurotomy for Cervical Facet Joint Pain. Journal of Spinal Disorders & Techniques, 21(6):406-408. doi: 10.1097/BSD.0b013e318158971f.

 

Repeat RFN Inquiry

  • DISCLAIMER

    At Metro Pain Group, we assess each patient’s condition individually. As leaders in pain intervention, we aim to provide advanced, innovative and evidence-based treatments tailored to suit the patient. The suitability of our procedures varies from patient to patient. If you would like to find out if this or other treatments are suitable for your specific condition, please speak to one of our doctors at the time of your consultation.

  • This field is for validation purposes and should be left unchanged.

Are you taking the right medication for your pain?

multidisciplinary team

Patients suffering from chronic pain often take codeine-based medications to relieve their pain. But do the side effects outweigh the positives?

Codeine-based medications which include Nurofen Plus, Panadeine Forte and Mersyndol are classified as an opioids. In Australia alone, opioid dispensing has surged 15-fold from 1992 – 2012. With this number, opioid-related hospitalisations and deaths have also increased. 1 While an effective short term treatment, taking opioids for several days or more can lead to physical dependence, abuse and overdose. 2 Patients with a physiological dependence suffer many withdrawal symptoms such as nausea, muscle aches, chills, diarrhoea and others. Some studies have also found that prescribing opioids as a long term treatment as simply ineffective. 3

It is a common misconception that opioids are the sole answer to chronic pain when in fact opioids can cause more harm than good. At Metro Pain Group, we offer alternatives to opioid based treatments. Our highly trained and experienced doctors adopt a comprehensive integrated approach and will work with you to find the treatment that is right for you.

 

References:
1Blanch, B., Pearson, S. and Haber, P. S. (2014), Prescribed opioid use in Australia. Br J Clin Pharmacol, 78: 1159-1166. doi:10.1111/bcp.12446.
2Volkow, N., McLellan, A. (2016), Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies. N Engl J Med 2016; 374:1253-1263 DOI: 10.1056/NEJMra1507771
3Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the Treatment of Chronic Pain: Controversies, Current Status, and Future Directions. Experimental and clinical psychopharmacology. 2008;16(5):405-416. doi:10.1037/a0013628.

 

If you would like to make an appointment, please fill out the form below.

Book an appointment

  • DISCLAIMER

    At Metro Pain Group, we assess each patient’s condition individually. As leaders in pain intervention, we aim to provide advanced, innovative and evidence-based treatments tailored to suit the patient. The suitability of our procedures varies from patient to patient. If you would like to find out if this or other treatments are suitable for your specific condition, please speak to one of our doctors at the time of your consultation.

  • This field is for validation purposes and should be left unchanged.

Dr Paul Verrills presented with the highly esteemed Best Research Paper Prize

multidisciplinary team

Dr Paul Verrills from Metro Pain Group has been announced as the prestigious winner of the Best Research Paper Prize for his presentation at the 87th Annual Scientific Congress of the Royal Australasian College of Surgeons in the section of Pain Medicine. The Congress was held on 7 – 11 May 2018 in Sydney, Australia.

The title of the research paper was “Investigating the Efficacy of High Frequency Spinal Cord Stimulation at 10 kHz for Treating Chronic Abdominal Pain: Interim Results from a Multicenter Feasibility Study”. Dr Paul Verrills in collaboration with a wider international team, presented the research findings from a spinal cord stimulation study which aims to assess the safety and effectiveness of HF10 Spinal Cord Stimulation (HF10-SCS) in the treatment of chronic abdominal pain. Unlike other spinal cord stimulation systems, HF10-SCS provides pain relief by producing wave forms at 10 kHz without paresthesia 1. HF10-SCS has previously established its ability to provide relief for chronic back and leg pain 2, and more recently for chronic abdominal pain, as presented by Dr Verrills at the Congress.

 

For more information on spinal cord stimulation, visit our website.

 

References:
1 Verrills P, Sinclair C, Barnard A. A review of spinal cord stimulation systems for chronic pain. Journal of Pain Research. 2016;9:481-492. doi:10.2147/JPR.S108884.
2 Leonardo Kapural, Cong Yu, Matthew W. Doust, Bradford E. Gliner, Ricardo Vallejo, B. Todd Sitzman, Kasra Amirdelfan, Donna M. Morgan, Lora L. Brown, Thomas L. Yearwood, Richard Bundschu, Allen W. Burton, Thomas Yang, Ramsin Benyamin, Abram H. Burgher; Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial. Anesthesiology 2015;123(4):851-860. doi: 10.1097/ALN.0000000000000774.

image_print

Keep up to date with all our latest news and information.

Join Our Mailing List

Subscribe to our mailing list